WHO Technical Report Series, No. 981 - World Health Organization
WHO Technical Report Series, No. 981 - World Health Organization
WHO Technical Report Series, No. 981 - World Health Organization
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Quality control – specifications and tests<br />
issues and was subsequently mailed out for public consultation. The comments<br />
received were collated by the secretariat for submission to the Expert Committee.<br />
It had been noted that the requirements of the monograph did not<br />
necessarily apply to preparations that were intended for any use other than by<br />
oral administration. It was pointed out that such non-oral preparations, for<br />
example, vaginal or rectal capsules, might require a special formulation, method<br />
of manufacture, or form of presentation appropriate to their particular use. Starch<br />
capsules (often known as cachets) are also not included in the monograph.<br />
The Expert Committee adopted the text as proposed.<br />
3.4.2 Proposal for revision of general monographs: parenteral preparations<br />
Following discussion at the May 2012 consultation, the draft general monograph<br />
on parenteral preparations was circulated for public consultation. The comments<br />
received were then collated by the secretariat in August and September 2012 in<br />
preparation for consideration by the Expert Committee.<br />
The proposed revisions of this general monograph were part of the review<br />
of general monographs endorsed by the Expert Committee at its forty-second<br />
meeting. Account was taken of recently adopted revised texts for 3.2 Test for<br />
sterility, 3.4 Test for bacterial endotoxins, 5.6 Extractable volume and 5.7 Test<br />
for particulate contamination.<br />
One of the major changes proposed in the revision was the required<br />
compliance of all parenteral preparations with tests for bacterial endotoxins<br />
(or, where justified, pyrogens). Consequently, a review of the individual<br />
monographs for injections is necessary, with the addition of a test and limit<br />
for bacterial endotoxins to each monograph that currently does not include<br />
such a requirement. It was noted that the requirements of the monograph<br />
did not necessarily apply to human blood and products derived from human<br />
blood, to immunological preparations, to peritoneal dialysis solutions or to<br />
radiopharmaceutical preparations.<br />
The Expert Committee proposed a number of changes to the draft and<br />
adopted the monograph subject to the amendments proposed.<br />
3.4.3 Proposal for revision of 5.1 Uniformity of<br />
content for single-dose preparations<br />
The preliminary draft of the revision of the chapter of The International<br />
Pharmacopoeia on uniformity of content for single-dose preparations was<br />
discussed at the consultation in May 2012. It was subsequently circulated for<br />
public consultation. Comments received were collated by the secretariat prior to<br />
the meeting of the Expert Committee.<br />
The Expert Committee noted that it was proposed to revise the text to<br />
bring it in line with the draft proposal for revision of the general monograph on<br />
11